Chemotherapy made from 'caterpillar fungus' shows early promise in clinical trials
CTV
An experimental cancer drug made from a molecule found in a Himalayan fungus known as ‘caterpillar fungus’ has shown early promise as a new treatment for patients with advanced tumors in a small clinical trial.
The new chemotherapy variety, known as NUC-7738 by researchers at the University of Oxford, is made from cordycepin, first found in a parasitic fungus species called Ophiocordyceps sinensis.
Commonly known as “caterpillar fungus,” thanks to its ability to kill and mummify moth larva in the wild, the active ingredient has been used as a herbal remedy in traditional Chinese medicine for centuries.
Now, researchers at the University of Oxford, in partnership with U.K.-based biopharmaceutical company NuCana, are testing the proposed anti-cancer, anti-oxidant, and anti-inflammatory effects of the compound in a small phase one trial involving 28 patients with advanced tumours that were resistant to conventional cancer treatment.
Cordycepin, referred as 3'-deoxyadenosine (or 3'-dA), is a naturally occurring nucleoside analogue. These analogues can be used in therapeutic drugs, including antiviral products used to prevent viral replication in infected cells.